Issuer
Replek AD Skopje
Issuer's basic data
Address
Ul.Kozle 188
City
Skopje
State
Makedonija
Mail
info@replek.com.mk
Contact person +
Suzana Milosevska
Phone
+389 2 3081352,<br/>+389 2 3081348
Fax
+389 2 3081352,<br/>+389 2 3081348
Prospectus
Year 2020 2019 2018
Total Revenue from operation Activities 1,251,407 1,049,284 974,868
Operating profit 184,976 152,880 112,145
Net profit 163,714 133,930 99,952
Equity 1,527,870 1,472,185 1,460,149
Total liabilities 589,007 442,997 362,042
Total assets 2,116,877 1,915,182 1,822,191
Market capitalization 2,695,680 1,988,771 1,815,437
* data in 000 MKD
Methodology
Year 2020 2019 2018
Return on sales 14.78% 14.57% 11.50%
Net earnings per share (EPS) 6,316.11 5,167.06 3,856.15
Return on assets 7.73% 6.99% 5.49%
Return on equity 10.72% 9.10% 6.85%
Price to earnings 16.47 14.85 18.16
Book value per share 58,945.59 56,797.26 56,332.92
Price to Book Value 1.76 1.35 1.24
Dividend Per Share 2,392.00 4,168.00 4,704.00
Dividend yield 2.30% 5.43% 6.72%
Replek AD Skopje is a company that primarily operates in the production of pharmaceutical products, supply and wholesale of medicaments, medical consumable materials and medical equipment. The company's core business is development, design and production of generic medicines in different pharmaceutical therapeutic categories, as oral dosage forms: tablets, capsules and oral solutions, as well as medicines for topical use (creams, ointments, solutions), by the Replekpharm - pharmaceutical factory, a daughter company of the REPLEK AD. Additionally, the Company operates pharmacies, engaged in retail supply of pharmaceuticals; running department store Replek Hubo Market, which offers various household products and a club restaurant.

General manager
Ivan Tudzarov 
Managing Board
Dusan Pecovski
Ivan Tudzarov
Zimbakova Danica
Liljana Makraduli
Milosevska Suzana
Supervisory Board 
Anastazija Joksimovik
Bojan Avramovski
Aleksandar Tomovski - President
Tomislav Dimovski

  1. Block trade

    Block trade with shares of Replek AD Skopje
  2. Block trade

    Block trade with shares of Replek AD Skopje
  3. Non-trade transfers of listed companies' share

    According to the data from the Central Securities Depositary we inform that the following non-trade transfers of listed companies' shares were executed
  4. Тrading in shares issued by Replek AD Skopje will continue

    Тrading in shares issued by Replek AD Skopje will continue
  5. Temporary suspension of trading in shares issued by Replek AD Skopje

    Temporary suspension of trading in shares issued by Replek AD Skopje
  6. Non-trade transfers of listed companies' share

    According to the data from the Central Securities Depositary we inform that the following non-trade transfers of listed companies' shares were executed
  7. Non-trade transfers of listed companies' share

    According to the data from the Central Securities Depositary we inform that the following non-trade transfers of listed companies' shares were executed
  8. Non-trade transfers of listed companies' share

    Non-trade transfers of listed companies' share
  9. Share buy-backs and non-trade transfers of listed companies' shares

    We inform you about executed share buy-backs and non-trade transfers of listed companies' shares
  10. Non-trade transfers of listed companies' share

    According to the data from the Central Securities Depositary we inform that the following non-trade transfers of listed companies' shares were executed
Symbols
Price movement
Volume
Symbol data
Market segment:
Exchange Listing - Ordinary shares
ISIN:
MKREPL101013
Total shares
25,920
Last trade: 6/15/2021
Max Price:
108,999.00
Min Price:
108,999.00
Avg Price:
108,999.00
Volume:
1
Value:
108,999
Trades:
1
Last 52 weeks
Max Price:
116,337.00
Min Price:
83,000.00
Volume:
1,262
Value:
138,210,012
Trades:
252

* the average price is from the last trading day

**data doesn't inculde block trades

*** the ordinary shares and the priority shares own by the Pension and Disability Insurance Fund of the Republic of Macedonia – PDIF (if they are issued) are summed up. The priority shares own by the PDIF are converted in ordinary shares at the moment of sale.

Historical Data